2511 — HighTide Therapeutics Share News
0.000.00%
- HK$1.59bn
- HK$1.40bn
Brief: Hightide Therapeutics Says Co And Individual Terminate Loan Agreement With Immediate Effect
Brief: Hightide Therapeutics Enters Loan Agreement Up To HK$15 Million
Brief: HighTide Therapeutics Says NMPA China Accepts New Drug Application For HTD1801
Brief: Hightide Therapeutics Posts HY Loss Attributable Of RMB120.3 Mln
Brief: Hightide Therapeutics Says Unit Commenced Collaborative Project
Brief: Hightide Therapeutics Inc To Place Up To 60.0 Million Shares
Brief: Hightide Therapeutics Updates On Phase 3 Trials Of Berberine Ursodeoxycholate
Brief: Hightide Therapeutics Noted Recent Unusual Fluctuation In Price Of Shares
Brief: Hightide Therapeutics Says FY Loss Attributable RMB939.3 Million
Brief: Hightide Therapeutics Plans To Expand Its Business Presence To Cover Hebei Province, China